Australia markets closed
Explore/

Most Active Small-Cap Stocks

Most Active Small-Cap Stocks

7.86k followers31 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the most active small-cap stocks by daily trading volume.

Curated by Yahoo Finance

Follow this list to discover and track the most active small-cap stocks by daily trading volume. Although small-cap stocks are generally associated with more risk, they can provide investors large upside potential.

The list includes stocks priced at $5 or more reflecting intraday volume. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.

This watchlist is similar to a discontinued watchlist called Small Cap Stars.

Background

Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.

Performance

WatchlistChange today1-month return1-year returnTotal return
Most Active Small-Cap Stocks+5.44%---
^GSPC-2.45%-0.53%+22.88%+4017.57%

31 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
GBTCGrayscale Bitcoin Trust (BTC)45.6365-2.76-5.71%3:59 pm GMT-512.39M16.26M8.02B
MACThe Macerich Company13.19-0.60-4.35%4:00 pm GMT-511.31M8.31M2.04B
XLXL Fleet Corp.14.54-0.10-0.68%4:00 pm GMT-58.54M10.41M1.91B
PINGPing Identity Holding Corp.23.34-9.07-27.99%4:00 pm GMT-57.63M1.04M1.90B
BLUEbluebird bio, Inc.28.12+2.20+8.49%4:00 pm GMT-58.33M1.74M1.89B
IPOESocial Capital Hedosophia Holdings Corp. V18.72-0.69-3.55%4:00 pm GMT-57.74M7.64M1.88B
BCRXBioCryst Pharmaceuticals, Inc.10.47-1.34-11.35%4:00 pm GMT-57.68M8.50M1.85B
PBFPBF Energy Inc.14.85-0.48-3.13%4:00 pm GMT-57.00M6.57M1.78B
PANDPandion Therapeutics, Inc.59.81+34.18+133.36%4:00 pm GMT-58.08M111.70k1.77B
ERJEmbraer S.A.8.94-0.75-7.74%4:00 pm GMT-59.69M3.60M1.68B
GEVOGevo, Inc.10.03-1.37-12.02%4:00 pm GMT-516.91M34.15M1.54B
OCGNOcugen, Inc.8-0.93-10.41%4:00 pm GMT-514.75M85.42M1.50B
CDXCChromaDex Corporation18.74+9.00+92.40%4:00 pm GMT-5116.70M523.51k1.17B
LOTZCarLotz, Inc.9.34-0.43-4.40%4:00 pm GMT-59.79M4.10M1.06B
EBONEbang International Holdings Inc.7.46+0.10+1.36%4:00 pm GMT-528.82M12.81M1.04B
RTPReinvent Technology Partners12-1.46-10.85%4:00 pm GMT-59.08M1.46M1.04B
VUZIVuzix Corporation18.08-0.81-4.29%4:00 pm GMT-56.52M4.98M1.01B
CXWCoreCivic, Inc.8.23+0.50+6.47%4:00 pm GMT-56.36M2.64M984.62M
GEOThe GEO Group, Inc.7.77+0.45+6.15%4:00 pm GMT-511.41M4.32M942.56M
VXRTVaxart, Inc.7.5+0.16+2.18%4:00 pm GMT-514.45M15.86M821.02M
SOSSOS Limited6.04-1.54-20.32%4:00 pm GMT-5104.18M28.03M749.33M
SOLOElectrameccanica Vehicles Corp.6.28-0.40-5.99%4:00 pm GMT-57.72M16.59M618.91M
CLVSClovis Oncology, Inc.5.94-0.26-4.19%4:00 pm GMT-512.20M7.78M614.39M
FRXForest Road Acquisition Corp.12.64-1.40-9.97%4:00 pm GMT-56.32M3.13M474.00M
GMBLEsports Entertainment Group, Inc.18.52+0.94+5.35%4:00 pm GMT-516.07M1.06M320.97M
KOSSKoss Corporation21.53+3.09+16.76%4:00 pm GMT-538.33M2.84M180.75M
WWRWestwater Resources, Inc.5.85-0.59-9.16%4:00 pm GMT-57.03M8.87M172.07M
SNSSSunesis Pharmaceuticals, Inc.5.32+1.04+24.30%4:00 pm GMT-570.24M3.17M96.33M
SCKTSocket Mobile, Inc.11.74+1.64+16.24%4:00 pm GMT-524.45M4.67M71.38M
SSNTSilverSun Technologies, Inc.7.71+0.46+6.34%4:00 pm GMT-513.36M143.78k34.70M
  • Nikola reports narrower loss than expected, shares rally
    Editor's pick
    Yahoo Finance

    Nikola reports narrower loss than expected, shares rally

    Nikola (NKLA) shares rallied after the electric-truck startup announced its fourth quarter results.

  • 4 tips for traders who want to leap into GameStop, other 'meme' stocks
    Editor's pick
    Yahoo Finance

    4 tips for traders who want to leap into GameStop, other 'meme' stocks

    Skybridge Capital co-chief investment officer Troy Gayeski shares some quick tips to those investors looking to trade GameStop's stock and other meme stocks.

  • Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket
    SmarterAnalyst

    Merck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares Skyrocket

    Merck & Company agreed to snap up Pandion Therapeutics, a clinical-stage biotechnology company, in a deal worth $1.85 billion. Pandion shares jumped almost 133.4% to close at $59.81 on Feb. 25. Per the terms of the deal, the pharmaceutical company will pay $60 per share in cash. Merck (MRK) will acquire all shares of Pandion through a subsidiary, which would initiate a tender offer. The tender offer will close subject to certain conditions. These include the conditions that at least a majority of the total number of Pandion’s fully-diluted common shares are tendered and the expiration of the waiting period is determined as per the Hart-Scott-Rodino Antitrust Improvements Act. Upon completion of the tender offer, the remaining shares of Pandion (PAND) will be canceled and converted into the right to receive at the price tag of $60 per share. The acquisition is likely to close in the first half of 2021. Pandion CEO Dr. Rahul Kakkar said, “Pandion grew out of our founders’ personal and scientific mission to change the way patients living with autoimmune diseases are treated.” “We are proud that Merck has recognized our team’s innovation and drive in creating a pipeline of diverse candidates that activate natural immune regulatory mechanisms and thereby have the potential to achieve better clinical responses for patients,” he added. (See Merck stock analysis on TipRanks) Following the deal, Mizuho Securities analyst Mara Goldstein maintained a Buy rating and a price target of $100. The analyst believes “MRK is augmenting its pipeline (with two clinical, three preclinical, and four discovery programs by YE21) ahead of the expected Organon & Co. Spin off (late 2Q21) with the acquisition of autoimmune-focused company Pandion.” The consensus rating among analysts is a Strong Buy based on 4 Buys versus 1 Hold. The average analyst price target stands at $94.40 and implies upside potential of 26.5% to current levels over the next 12 months. Additionally, Merck scores a 9 out of 10 from TipRanks’ Smart Score rating system, indicating that the stock has strong potential to outperform market expectations. Related News: Western Alliance To Buy AmeriHome For $1B; Shares Drop 3.5% Redfin To Buy RentPath For $608M; Shares Jump 12% Autodesk To Snap Up Innovyze For $1B; Street Sees 14% Upside More recent articles from Smarter Analyst: Beyond Meat Posts Mixed 4Q Results; Street Says Hold Domino’s 4Q Results Miss Analysts’ Expectations; Shares Tank 7% Moderna 4Q Revenues Jump To $571M On Back Of COVID-19 Vaccine; Shares Rise 4% Billionaire Ken Griffin Pulls the Trigger on These 2 Penny Stocks